Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus

Eur J Immunol. 2017 Jul;47(7):1200-1210. doi: 10.1002/eji.201646822. Epub 2017 May 22.

Abstract

IFN-γ-producing T helper 1 (Th1) cell responses mediate protection against infections but uncontrolled Th1 activity also contributes to a broad range of autoimmune diseases. Autocrine complement activation has recently emerged as key in the induction and contraction of human Th1 immunity: activation of the complement regulator CD46 and the C3aR expressed by CD4+ T cells via autocrine generated ligands C3b and C3a, respectively, are critical to IFN-γ production. Further, CD46-mediated signals also induce co-expression of immunosuppressive IL-10 in Th1 cells and transition into a (self)-regulating and contracting phase. In consequence, C3 or CD46-deficient patients suffer from recurrent infections while dysregulation of CD46 signaling contributes to Th1 hyperactivity in rheumatoid arthritis and multiple sclerosis. Here, we report a defect in CD46-regulated Th1 contraction in patients with systemic lupus erythematosus (SLE). We observed that MMP-9-mediated increased shedding of soluble CD46 by Th1 cells was associated with this defect and that inhibition of MMP-9 activity normalized release of soluble CD46 and restored Th1 contraction in patients' T cells. These data may deliver the first mechanistic explanation for the increased serum CD46 levels observed in SLE patients and indicate that targeting CD46-cleaving proteases could be a novel avenue to modulate Th1 responses.

Keywords: Autoimmunity; CD46; Complement; Innate immunity; Membrane cofactor protein; T cell; Th1.

MeSH terms

  • Adult
  • Autoimmunity
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Complement Activation
  • Female
  • Humans
  • Immunity, Innate
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Interleukin-10 / pharmacology
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Membrane Cofactor Protein / blood
  • Membrane Cofactor Protein / deficiency
  • Membrane Cofactor Protein / immunology*
  • Membrane Cofactor Protein / metabolism*
  • Signal Transduction
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology*

Substances

  • CD46 protein, human
  • IL10 protein, human
  • Matrix Metalloproteinase Inhibitors
  • Membrane Cofactor Protein
  • Interleukin-10
  • Matrix Metalloproteinase 9